| 2.1 -0.11 (-4.98%) | 04-29 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.94 | 1-year : | 3.32 |
| Resists | First : | 2.51 | Second : | 2.84 |
| Pivot price | 2.19 |
|||
| Supports | First : | 1.98 | Second : | 1.64 |
| MAs | MA(5) : | 2.2 |
MA(20) : | 2.21 |
| MA(100) : | 2.34 |
MA(250) : | 2.18  |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 57.4 |
D(3) : | 61.9 |
| RSI | RSI(14): 38.9 |
|||
| 52-week | High : | 3.14 | Low : | 1.39 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ NXGL ] has closed below the lower bollinger band by 4.5%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 68.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.16 - 2.17 | 2.17 - 2.18 |
| Low: | 2.07 - 2.09 | 2.09 - 2.1 |
| Close: | 2.08 - 2.1 | 2.1 - 2.12 |
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Tue, 02 Apr 2024
NEXGEL, Inc. (NASDAQ:NXGL) Q4 2023 Earnings Call Transcript - Yahoo Finance
Mon, 01 Apr 2024
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year - Yahoo Finance
Wed, 27 Mar 2024
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8 ... - GlobeNewswire
Fri, 15 Mar 2024
NXGL Stock Quote Price and Forecast - CNN
Mon, 04 Mar 2024
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th - GlobeNewswire
Thu, 29 Feb 2024
NEXGEL, Inc. (NASDAQ:NXGL): Are Analysts Optimistic? - Simply Wall St
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 6 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 22.8 (%) |
| Held by Institutions | 2.2 (%) |
| Shares Short | 24 (K) |
| Shares Short P.Month | 15 (K) |
| EPS | -0.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.81 |
| Profit Margin | -77.3 % |
| Operating Margin | -142.6 % |
| Return on Assets (ttm) | -21.4 % |
| Return on Equity (ttm) | -49.8 % |
| Qtrly Rev. Growth | 106.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.65 |
| EBITDA (p.s.) | -0.53 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -3.75 |
| PEG Ratio | 0 |
| Price to Book value | 2.56 |
| Price to Sales | 3.19 |
| Price to Cash Flow | -4.04 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|